Rutgers is among five sites around the country designated as a National Institutes of Health’s Research Evaluation and Commercialization Hub (REACH) to speed up the commercialization of biomedical discoveries into viable diagnostics, devices, and therapeutics, improve patient care, enhance health and train the next generation of innovators.
Image: Eileen White (left), Distinguished Professor of Molecular Biology and Biochemistry with postdoctoral fellow Akshada Sawant at the Cancer Institute of New Jersey, one of the centers and institutes that will work to identify innovative health-related technologies for possible commercialization. Photo: Robert Essel
